THỰC TRẠNG ĐIỀU TRỊ BỆNH NHÂN HIV BẰNG LAMIVUDIN, TENOFOVIR, DOLUTEGRAVIR TẠI BỆNH VIỆN ĐA KHOA LONG AN

Abstract

Objective: To describe the treatment status of HIV patients with Lamivudine, Tenofovir, and
Dolutegravir at Long An General Hospital.
Subjects and methods: Retrospectively describe over 80 HIV/AIDS-infected patients being treated
with a 3-drug regimen using Lamivudine 300mg, Tenofovir 300mg, Dolutegravir 50mg of inpatient
and outpatient treatment at the Department of Infectious Diseases, Long An General Hospital.
Results: Male patients accounted for the majority (58.8%); average age was 34.3 ± 7.1 years old. The
majority of patients started at stages 1 and 2 (62.6%) and maintained during treatment. Regarding the
immune stage, the majority of patients treated at the stage of significant and severe immunodeficiency
accounted for 26.3% and 28.8%, respectively. There were 100.0% of patients started treatment with
TDF/3TC/DTG regimen (Acriptega).
Conclusion: The majority of patients began in stages 1 and 2. The majority of patients were treated
at the stage of significant and severe immunodeficiency. Patients started treatment with TDF/3TC/
DTG regimen (Acriptega).